Strategic Approach and CMC Considerations for a Novel Pediatric Nasal Vaccine Development
Time: 11:00 am
day: Conference Day Two
Details:
- Unveiling the roadmap and key elements for a novel nasal vaccine product development, encompassing both formulation and intranasal delivery device
- Exploring challenges, CMC, and regulatory considerations. Sharing insights with valuable tools applied from recent successful experiences with a new vaccine candidate, spanning from pre-clinical stages to Phase 3 development for accelerating and de-risking the novel vaccine development process
- Touching upon some future perspectives in nasal delivery
